Key Statistics
Market Cap
$9.17B
P/E Ratio
85.77
Dividend Yield
0.00%
Volume
1,230,035
Avg Volume
846,244
52-Week High
$117.33
52-Week Low
$28.66
About Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
Analyst Ratings
View All →
Avg Price Target
$140.00
(+313.3% upside)
